In the Original Investigation titled “Comparative Effectiveness of Immune Checkpoint Inhibitors vs Chemotherapy by Tumor Mutational Burden in Metastatic Castration-Resistant Prostate Cancer,”[1] published March 31, 2022, the labels for the numbers at risk in Figure 3 were reversed and there was a typographical error in Figure 4. This article has been corrected.[1]
Authors: Ryon P Graf; Virginia Fisher; Janick Weberpals; Ole Gjoerup; Marni B Tierno; Richard S P Huang; Nicolas Sayegh; Douglas I Lin; Kira Raskina; Alexa B Schrock; Eric Severson; James F Haberberger; Jeffrey S Ross; James Creeden; Mia A Levy; Brian M Alexander; Geoffrey R Oxnard; Neeraj Agarwal Journal: JAMA Netw Open Date: 2022-03-01